I tend to agree. It might not change the world as much as the potential of 12CQ, but, might just be easier to bring to market than 12CQ and easier to sell. There can be an immediate use for the biosensors but there might not be too much of an immediate use for the 12CQ. Yet. I'm envisioning the biochip holding the company strong whilst the 12CQ development is ongoing.
Ann: Electronic control of biochip gFET sensitivity achieved, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $71.35M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.0¢ | $32.59K | 114.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17601 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 58500 | 2 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| AXE (ASX) Chart |